Strata Oncology to Present at 40th Annual J.P. Morgan Health Care Conference

January 6, 2022 |

1 min read

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced that its co-founder and Chief Executive Officer, Dan Rhodes, Ph.D., will present at the 40th Annual J.P. Morgan Health Care Conference, being held virtually from January 10-13.

ANN ARBOR, Mich., Jan. 6, 2022 /PRNewswire/ -- Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced that its co-founder and Chief Executive Officer, Dan Rhodes, Ph.D., will present at the 40th Annual J.P. Morgan Health Care Conference, being held virtually from January 10-13.

Presentation Information
Date: Wednesday, January 12, 2022
Time: 08:00 AM - 08:25 AM EST

About Strata Oncology
Strata Oncology, Inc. is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer. The company combines molecular profiling, real-world data, and a large-scale clinical trial platform to identify and deliver optimal treatments for patients with cancer. For more information visit strataoncology.com.

Media Inquiries:
Renee Volpini
917.923.8117
renee.volpini@westwicke.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/strata-oncology-to-present-at-40th-annual-jp-morgan-health-care-conference-301455321.html

SOURCE Strata Oncology, Inc.

Events